Abiopharma

🔍 Charlton Henry L (Executive)

Company: INTUITIVE SURGICAL INC (ISRG)

Report Date: 2026-02-26

Detailed Transactions and Holdings:

• Acquired 1,717 shares of Common Stock (Direct)
  Date: 2026-02-26 | Code: M | equity_swap_involved: 0 | shares_owned_after: 5,414.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 765 shares of Common Stock at $506.17 per share (Direct)
  Date: 2026-02-26 | Code: F | equity_swap_involved: 0 | shares_owned_after: 4,649.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 1,030 shares of Common Stock (Direct)
  Date: 2026-02-26 | Code: M | equity_swap_involved: 0 | shares_owned_after: 5,679.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 459 shares of Common Stock at $506.17 per share (Direct)
  Date: 2026-02-26 | Code: F | equity_swap_involved: 0 | shares_owned_after: 5,220.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 3,591 shares of Performance Stock Units - 2-28-2023 (Derivative)
  Date: 2026-02-26 | Code: A | equity_swap_involved: 0 | shares_owned_after: 10,773.00 | transaction_form_type: 4 | Footnotes: F2, F2
• Sold 1,717 shares of Restricted Stock Units - 2-26-2024 (Derivative)
  Date: 2026-02-26 | Code: M | equity_swap_involved: 0 | shares_owned_after: 3,434.00 | transaction_form_type: 4 | Footnotes: F3, F3
• Sold 1,030 shares of Restricted Stock Units - 2-26-2025 (Derivative)
  Date: 2026-02-26 | Code: M | equity_swap_involved: 0 | shares_owned_after: 3,090.00 | transaction_form_type: 4 | Footnotes: F3, F3
• Acquired 4,032 shares of Restricted Stock Units - 2-26-2026 (Derivative)
  Date: 2026-02-26 | Code: A | equity_swap_involved: 0 | shares_owned_after: 4,032.00 | transaction_form_type: 4 | Footnotes: F3, F3

Footnotes:

• F1: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25% of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.
• F2: Represents performance stock units ("PSUs") initially granted to the Reporting Person on February 28, 2023 subject to achievement of certain performance metrics. The performance criteria for the PSUs reported herein have been achieved, as determined by the Compensation Committee of the Issuer. The PSUs reported herein vest on February 28, 2026, the third anniversary of the grant date, subject to Reporting Person's continuous service to the Issuer through each such vesting date.
• F3: Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period.